RALLYBIO CORPORATION (RLYB)

RALLYBIO CORPORATION (RLYB) scores 51 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 0.01, representing a 100% premium to fair value. Quantitative score: 44/100. Qualitative score: 90/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full RLYB analysis on boothcheck